세계의 외과용 블레이드 시장 : 규모, 점유율, 동향 분석 - 제품별, 소재별, 최종 용도별, 지역별, 부문 예측(2024-2030년)

Surgical Blade Market Size, Share & Trends Analysis Report By Product (Stainless Steel, High-grade Carbon Steel), By Material, By End Use (Hospitals, Clinics), By Region, And Segment Forecasts, 2024 - 2030

US $ 5,950 ￦ 8,443,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,862,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,700,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

수술용 블레이드 시장의 성장과 동향 :

세계 수술용 블레이드 시장 규모는 2024-2030년에 걸쳐 CAGR 5.30%로 성장하여 2030년에는 2억 8,908만 달러에 달할 것으로 예측됩니다.

사고 건수 증가에 의한 수술 건수 증가와 다양한 장애를 일으키기 쉬운 노인 인구 증가가 현재 시장을 견인하고 있습니다. 게다가, 세계적으로 수술의 수가 증가함에 따라 외과용 블레이드 수요가 증가하고 있습니다.

일부 주요 기업들은 혁신적인 신제품을 출시하기 위해 R&D에 투자하고 있습니다. 개인의 가처분 소득과 생활수준의 향상, 현대적인 수술에 관한 의식의 높아짐도, 의료 처치의 건수를 증가시키고 있는 요인입니다. 외과 수술이 필요한 외상 사례와 암과 같은 질병 증가는 외과용 블레이드 수요를 더욱 증가시키고 있습니다. 게다가, 다양한 질병에 대한 수술적 개입에 대응할 수 있는 다양한 형상과 크기의 블레이드가 이용가능하다는 것도 시장 전체를 견인하고 있습니다.

건강 관리에서 광범위한 치료를 통해 더 많은 환자들이 합리적인 가격과 실현 가능성을 향상시켜 새로운 치료를 받기를 원합니다. 스테인레스 스틸 블레이드는 더 깨끗한 절개, 뛰어난 날카로움, 암컷 무늬 번호 매기기 등의 특징으로 점점 더 선호됩니다. 위험이 낮은 의료기기이기 때문에 이러한 제품에는 엄격한 규제 프로세스가 필요 없으며 제품 출시를 촉진하고 쉽게 만들 수 있습니다.

외과용 블레이드 시장 보고서 하이라이트

• 외과용 블레이드에는 다양한 모양이 있으며, 외과의사와 의료진은 의료 절차에 적합한 블레이드를 선택할 수 있습니다.
• 제품별로는 스테인레스 스틸 블레이드가 보다 우수한 내식성을 갖추고 있기 때문에 예측 기간 동안 시장을 선도할 것으로 보입니다. 다량의 생리 식염수와 여러 절개를 동반 한 치료에 적합합니다.
• 소재별로는 멸균 블레이드가 시장을 독점할 것으로 예측됩니다. 멸균 블레이드는 높은 효율로 날카로운 절삭날을 제공할 수 있어 보다 깨끗한 절개와 우수한 절단을 가능하게 하기 때문입니다.
• 최종 용도별로 병원 부문은 예측 기간 동안 42.52% 이상의 점유율을 차지합니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 외과용 블레이드 시장의 변수, 동향, 범위

• 시장 계통 전망
  • 상위 시장 전망
  • 보조 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
  • 산업 분석 - Porter's Five Forces 분석
  • PESTEL 분석

제4장 외과용 블레이드 시장 : 제품의 추정·동향 분석

• 부문 대시보드
• 외과용 블레이드 시장 : 제품의 변동 분석, 100만 달러, 2023년·2030년

제5장 외과용 블레이드 시장 :소재의 추정·동향 분석

• 부문 대시보드
• 외과용 블레이드 시장 : 소재의 변동 분석, 100만 달러, 2023년?2030년

제6장 외과용 블레이드 시장 : 최종 용도의 추정·동향 분석

• 부문 대시보드
• 외과용 블레이드 시장 : 최종 용도의 변동 분석, 100만 달러, 2023년?2030년

제7장 외과용 블레이드 시장 :지역의 추정·동향 분석

• 지역별 시장 점유율 분석, 2023년·2030년
• 지역 시장 대시보드
• 세계의 지역 시장 현황
• 시장 규모, 예측 동향 분석, 2018-2030년:
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 노르웨이
  • 스웨덴
  • 덴마크
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제8장 경쟁 구도

• 주요 시장 진출기업에 의한 최근의 동향과 영향 분석
• 기업/경쟁의 분류
• 벤더 상황
  • 주요 기업의 시장 점유율 분석, 2023년
    • Medtronic Plc
    • Johnson &Johnson Service, Inc.
    • Commed Corporation
    • Integra LifeSciences
    • Smith & Nephew
    • Becton, Dickinson and Company(BD)
    • B. Braun Melsungen Ag
    • Cadence Inc
    • Integer Holdings Corporation
    • Olympus Corporation
    • Stryker
    • Boston Scientific Corporation
    • Erbe Elektromedizin Gmbh
    • 3M Healthcare

JHS

영문 목차

영문목차

Surgical Blade Market Growth & Trends:

The global surgical blade market size is expected to reach USD 289.08 million by 2030, registering a CAGR of 5.30% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increase in surgeries due to increase in number of accidents, coupled with a growing geriatric population prone to various disorders, is currently driving the market. Moreover, increase in number of surgeons at a global scale is also propelling the demand for surgical blades.

Several key players are investing in R&D to launch new and innovative products. Increase in individual disposable income & standard of living, and growth in awareness regarding modern surgical procedures are other factors increasing the number of medical procedures. Increase in trauma cases and other disorders, such as cancer, which require surgery, is further augmenting demand for surgical blades. Furthermore, availability of these blades in various shapes and sizes for surgical intervention in multiple illnesses is driving the overall market.

With a wide range of procedures in healthcare, more patients are willing to undergo new treatments due to improving affordability and feasibility. Stainless steel blades are increasingly preferred due to features such as cleaner incisions, superior cutting, and numbering of scalpel handles. Being low-risk medical tools, these products do not need strict regulatory processes, which encourages and eases product launches.

Surgical Blade Market Report Highlights:

• Surgical blades come in a variety of forms, enabling surgeons and medical staff to choose the right blade for a medical procedure
• By product, stainless steel blades are expected to lead market over the forecast period, due to better anti-corrosion properties. They are more suitable for procedures involving large volumes of saline solution and multiple incisions
• By material, sterile blades are expected to dominate the market since they can provide a sharp cutting edge for high efficiency, enabling cleaner incisions and superior cutting
• By end use, hospitals segment accounted for a share of over 42.52% over the forecast period

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Material
  • 1.2.3. End Use
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Material Outlook
  • 2.2.3. End Use Outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Surgical Blade Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
  • 3.2.3. Industry Analysis - Porter's
    • 3.2.3.1. Bargaining power of the suppliers
    • 3.2.3.2. Bargaining power of the buyers
    • 3.2.3.3. Threats of substitution
    • 3.2.3.4. Threats from new entrants
    • 3.2.3.5. Competitive rivalry
  • 3.2.4. PESTEL Analysis
    • 3.2.4.1. Political landscape
    • 3.2.4.2. Economic and Social landscape
    • 3.2.4.3. Technological landscape

Chapter 4. Surgical Blade Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Surgical Blade Market: Product Movement Analysis, USD Million, 2023 & 2030
  • 4.2.1. Stainless Steel
    • 4.2.1.1. Stainless Steel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.2.2. High-grade carbon steel
    • 4.2.2.1. High-grade Carbon Steel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.2.3. Other
    • 4.2.3.1. Other Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Surgical Blade Market: Material Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Surgical Blade Market: Material Movement Analysis, USD Million, 2023 & 2030
  • 5.2.1. Sterile
    • 5.2.1.1. Sterile Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.2.2. Non-sterile
    • 5.2.2.1. Non-sterile Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Surgical Blade Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Surgical Blade Market: End Use Movement Analysis, USD Million, 2023 & 2030
  • 6.2.1. Hospitals
    • 6.2.1.1. Hospitals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.2.2. Clinics
    • 6.2.2.1. Clinics Facilities Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.2.3. Ambulatory Surgical Centers
    • 6.2.3.1. Ambulatory Surgical Centers Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Surgical Blade Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2023 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Global Regional Market Snapshot
• 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.5. North America
  • 7.5.1. U.S.
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework/ reimbursement structure
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.2. Canada
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework/ reimbursement structure
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.3. Mexico
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework/ reimbursement structure
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Europe
  • 7.6.1. UK
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework/ reimbursement structure
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.2. Germany
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework/ reimbursement structure
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.3. France
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Regulatory framework/ reimbursement structure
    • 7.6.3.3. Competitive scenario
    • 7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.4. Italy
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Regulatory framework/ reimbursement structure
    • 7.6.4.3. Competitive scenario
    • 7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.5. Spain
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. Regulatory framework/ reimbursement structure
    • 7.6.5.3. Competitive scenario
    • 7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.6. Norway
    • 7.6.6.1. Key country dynamics
    • 7.6.6.2. Regulatory framework/ reimbursement structure
    • 7.6.6.3. Competitive scenario
    • 7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.7. Sweden
    • 7.6.7.1. Key country dynamics
    • 7.6.7.2. Regulatory framework/ reimbursement structure
    • 7.6.7.3. Competitive scenario
    • 7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.8. Denmark
    • 7.6.8.1. Key country dynamics
    • 7.6.8.2. Regulatory framework/ reimbursement structure
    • 7.6.8.3. Competitive scenario
    • 7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. Asia Pacific
  • 7.7.1. Japan
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework/ reimbursement structure
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.2. China
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework/ reimbursement structure
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.3. India
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework/ reimbursement structure
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.4. Australia
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework/ reimbursement structure
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.5. South Korea
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Regulatory framework/ reimbursement structure
    • 7.7.5.3. Competitive scenario
    • 7.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.6. Thailand
    • 7.7.6.1. Key country dynamics
    • 7.7.6.2. Regulatory framework/ reimbursement structure
    • 7.7.6.3. Competitive scenario
    • 7.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 7.8. Latin America
  • 7.8.1. Brazil
    • 7.8.1.1. Key country dynamics
    • 7.8.1.2. Regulatory framework/ reimbursement structure
    • 7.8.1.3. Competitive scenario
    • 7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8.2. Argentina
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Regulatory framework/ reimbursement structure
    • 7.8.2.3. Competitive scenario
    • 7.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 7.9. MEA
  • 7.9.1. South Africa
    • 7.9.1.1. Key country dynamics
    • 7.9.1.2. Regulatory framework/ reimbursement structure
    • 7.9.1.3. Competitive scenario
    • 7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9.2. Saudi Arabia
    • 7.9.2.1. Key country dynamics
    • 7.9.2.2. Regulatory framework/ reimbursement structure
    • 7.9.2.3. Competitive scenario
    • 7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9.3. UAE
    • 7.9.3.1. Key country dynamics
    • 7.9.3.2. Regulatory framework/ reimbursement structure
    • 7.9.3.3. Competitive scenario
    • 7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9.4. Kuwait
    • 7.9.4.1. Key country dynamics
    • 7.9.4.2. Regulatory framework/ reimbursement structure
    • 7.9.4.3. Competitive scenario
    • 7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
• 8.3. Vendor Landscape
  • 8.3.1. Key company market share analysis, 2023
  • 8.3.2. Medtronic Plc
    • 8.3.2.1. Company overview
    • 8.3.2.2. Financial performance
    • 8.3.2.3. Product benchmarking
    • 8.3.2.4. Strategic initiatives
  • 8.3.3. Johnson & Johnson Service, Inc.
    • 8.3.3.1. Company overview
    • 8.3.3.2. Financial performance
    • 8.3.3.3. Product benchmarking
    • 8.3.3.4. Strategic initiatives
  • 8.3.4. Conmed Corporation
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Integra LifeSciences
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Smith & Nephew
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. Becton, Dickinson and Company (BD)
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. B. Braun Melsungen Ag
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. Cadence Inc
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. Integer Holdings Corporation
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives
  • 8.3.11. Olympus Corporation
    • 8.3.11.1. Company overview
    • 8.3.11.2. Financial performance
    • 8.3.11.3. Product benchmarking
    • 8.3.11.4. Strategic initiatives
  • 8.3.12. Stryker
    • 8.3.12.1. Company overview
    • 8.3.12.2. Financial performance
    • 8.3.12.3. Product benchmarking
    • 8.3.12.4. Strategic initiatives
  • 8.3.13. Boston Scientific Corporation
    • 8.3.13.1. Company overview
    • 8.3.13.2. Financial performance
    • 8.3.13.3. Product benchmarking
    • 8.3.13.4. Strategic initiatives
  • 8.3.14. Erbe Elektromedizin Gmbh
    • 8.3.14.1. Company overview
    • 8.3.14.2. Financial performance
    • 8.3.14.3. Product benchmarking
    • 8.3.14.4. Strategic initiatives
  • 8.3.15. 3M Healthcare
    • 8.3.15.1. Company overview
    • 8.3.15.2. Financial performance
    • 8.3.15.3. Product benchmarking
    • 8.3.15.4. Strategic initiatives

관련자료